The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year follow-up

European Journal of Heart Failure

Volumn 8, Issue 3, 2006, Pages 257-262

  Neverdal, Nils O ^a   Knudsen, Cathrine Wold ^a   Husebye, Trygve ^a   Vengen, Øystein A ^a   Pepper, John ^b   Lie, Mons ^a   Tønnessen, Theis ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Aortic stenosis; Aortic valve replacement; BNP; Left ventricular hypertrophy; Regression; Remodeling

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

AGE DISTRIBUTION; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCANNING ELECTRON MICROSCOPY;

EID: 33646355687     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.08.004     Document Type: Article

References (23)

1. Ogawa Y., Nakao K., Mukoyama M., et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 69 (1991) 355-365
2. Vanderheyden M., Goethals M., Verstreken S., et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 44 (2004) 2349-2354
3. Kohno M., Horio T., Yokokawa K., et al. Brain natriuretic peptides as a cardiac hormone in essential hypertension. Am J Med 92 (1992) 29-34
4. Maisel A.S., Krishnaswamy P., Nowak R.M., et al., The breathing not properly multinational study investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
5. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
6. Ogawa Y., Tamura N., Chusho H., and Nakao K. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol 79 (2001) 723-729
7. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209
8. Schiller N.B., Maurer G., Ritter S.B., et al. Transesophageal echocardiography. J Am Soc Echocardiogr 2 (1989) 354-357
9. Ikeda T., Matsuda K., Itoh H., et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 133 (1997) 307-314
10. Yoshibayashi M., Kamiya T., Saito Y., and Matsuo H. Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy. N Engl J Med 329 (1993) 433-434
11. Qi W., Mathisen P., Kjekshus J., et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 142 (2001) 725-735
12. Weber M., Arnold R., Rau M., Elsaesser A., Brandt R., Mitrovic V., et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 26 (2005) 1023-1030
13. Georges A., Forestier F., Valli N., Plogin A., Janvier G., and Bordenave L. Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur J Cardiothorac Surg 25 (2004) 941-945
14. Qi W., Mathisen P., Kjekshus J., et al. The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis. Clin Cardiol 25 (2002) 174-180
15. Pemberton C.J., Johnson M.L., Yandle T.G., and Espiner E.A. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 36 (2000) 355-359
16. Krayenbuehl H.P., Hess O.M., Monrad E.S., Schneider J., Mall G., and Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 79 (1989) 744-755
17. Lund O., Kristensen L.H., Baandrupt U., et al. Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. Eur Heart J 19 (1998) 1099-1108
18. Gardner D.G. Natriuretic peptides: markers or modulators of cardiac hypertrophy?. Trends Endocrinol Metab 14 (2003) 411-416
19. Nageh T., Chin D., Cooke J.C., Meehan N., Monaghan M.J., and Sherwood R.A. Interpretation of plasma brain natriuretic peptide concentrations may require adjustment for patient's age. Ann Clin Biochem 39 (2002) 151-153
20. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahony D.W., Baily K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
21. Tamura N, Ogawa Y, Chusho H, et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. PNAS;97:4239-44.
22. Clarkson P.B.M., Wheeldon N.M., MacFayden R.J., Pringle S.D., and MacDonald T.M. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation 93 (1996) 2037-2042
23. Hogenhuis J., Voors A.A., Jaarsma T., Hillege H.L., Boomsma F., and van Veldhuisen D.J. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail 7 (2005) 81-86